1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island

370

companies

as of February 29, 2024

Companies are divided into categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the minor field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

Business sector search resultsDrug Discovery

110of Results 41

Re-search in Business sector
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. >

Location search results

110of Results 41

Re-search in Location
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. >

You can select the initial.

Initial search results

110of Results 41

Re-search in Initial
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. >

AlliedCel Corporation

Major field:Regenerative Medicine

Miner field:Drug Discovery

Miner field:Production of Drugs and Quasi Drugs

Asahi Lab Commerce, Inc.

Major field:Chemical Synthesis

Miner field:Drug Discovery

Miner field:Distributor

Import state-of-the-art scientific instruments and sterile consumables and sell them to Academia and industries.

Overview

Asahi Lab Commerce, Inc. is one of leading distributors in the market of life science and bio science. We cover entire Japan providing sales, technical service and application. We represent unparallel products from EU, US and Asia to contribute life science and bio science field in Japan. We are always close to the clients and aim to have customer’s satisfaction not seeking only for profit.

Product / Service / PR

    ・The Benchtop NMR Spinsolve does not require He / N2 gas. Measurement is
     possible anywhere if there is a power supply.
     Monitor reaction processes in real time. 43MHz 60MHz 80MHz nuclide can add 3
     nuclides from 13C, 31P, 11B etc. based on 1H19F.
    ・The Netherlands Flowid SpinPro is a hybrid synthesizer with centrifugal force and
     flow, suitable for slurry and high viscosity samples.
    ・UK HEL manufactures products that excel at high-temperature and high-pressure
     reactions, such as gas-liquid mixing flow system FlowCAT and batch type HP
     ChemScan.
    ・UK Asynt manufactures compact CSTR fReactor, US Celltreat manufactures sterile
     disposable products, and offers serological pipettes, bioreaction tubes, pasteur
     pipettes, cell culture dishes, microplates, cryogenic tubes, and various bottles.
Address: 4-1-1 Minatojima-nakamchi, Chuo-Ku Kobe, 650-0046 JAPAN  (Contact Person Aritaka Kanayama)
TEL: +81-78-335-8613 FAX: +81-78-335-8614
Web site: http://www.asahilab.co.jp/ E-mail: kanayama@asahilab.co.jp

Bayer Yakuhin, Ltd.

Major field:Assisting Businesses, Rental Laboratories and Offices

Miner field:Drug Discovery

Operation of CoLaborator Kobe, an incubation space with fully-furnished lab and office infrastructure.

BioSafety Research Center Inc.

Major field:Contract Research

Miner field:Drug Discovery

Carna Biosciences, Inc.

Major field:Drug Discovery

Miner field:Genomics

Miner field:Contract Research

Drug discovery business and drug discovery support business

Overview

Carna Biosciences, Inc. is a biotech company established in April 2003 in Kobe as a spin-off company from Japanese research unit of NV Organon and is listed on Tokyo Stock Exchange JASDAQ Growth.
We conduct research and development to discover novel kinase inhibitors and provide drug discovery supporting services based on the drug discovery platform technology that have been acquired through many years of research and development experiences.

Product / Service / PR

    Carna Biosciences is focused on the discovery and development of kinase inhibitor drugs to treat serious unmet medical needs in oncology, autoimmune and neurological diseases by inhibiting kinases that are important drivers for those diseases.
    Carna Biosciences also provides high quality kinase proteins, accurate screening and profiling services, assay kits and assay development that satisfy customer needs, and cell-based assay services, playing an important role in kinase inhibitor drug discovery conducted by global pharmaceutical companies.
Address: BMA 3F, 1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047  (Contact Person Corporate Planning)
TEL: +81-78-302-7039 FAX: +81-78-302-6665
Web site: https://www.carnabio.com/english/ E-mail: ir-team@carnabio.com

Celaid Therapeutics Inc.

Major field:Regenerative Medicine

Miner field:Drug Discovery

Miner field:Outsourcing Business for Hospital

Development of new cell therapies for hematological and immunological diseases by using “Hematopoietic stem cells (HSC)”

Overview

Celaid Therapeutics is a startup biotech company in Japan to develop cell therapy products by using Hematopoietic stem cells (HSC), the source of human blood, for the treatment of hematological and immunological diseases, such as leukemia.
In the treatment of blood cancers, a certain amount of HSC must be transplanted to cure the disease. Our business aims to increase the number of HSC and provide them to hematological malignancy patients as a new innovative cell therapy product.

Product / Service / PR

    We primarily focus to develop cell therapy products that can solve various issues in current HSC transplantation by ex vivo expansion of HSC derived from umbilical cord blood. Compared to bone marrow transplants, cord blood-derived HSCs have the following advantages: shorter preparation time for procurement, less stringent HLA matching requirements, and lower risk of side effects after transplantation.
Address: Utokyo Entrepreneur Lab., South Clinical Research Bldg., 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8485, Japan  (Contact Person Atsuya Yamamura)
TEL: +81-50-3612-7767
Web site: https://celaidtx.com/en/ E-mail: contact@celaidtx.com

Hirosaki Life science Innovation, Inc.

Major field:Regenerative Medicine

Miner field:Drug Discovery

Development, manufacturing, and marketing of regenerative medicine products

Overview

Development, manufacturing and supply of regenerative and other medical products

Product / Service / PR

    Based on the results of an investigator-led clinical trial conducted by Kobe University and Foundation for Biomedical Research and Innovation (FBRI), Hirosaki Life science Innovation, Inc. is preparing for the pivotal clinical trial of IK-01, which is a collagen matrix containing chondrocytes indicated for focal articular cartilage defects in the knee, to obtain the marketing authorization.
Address: Kojimachi 285 Building 2F, Kojimachi 2-8-5,Chiyodaku Tokyo, 102-0083 Japan  (Contact Person Youichiro Machida)
TEL: +81-36-457-9861 FAX: +81-36-261-4445
Web site: http://hirosaki-li.co.jp/company.html E-mail: y-machida@hirosaki-li.co.jp

Institute of Oriental Medical Science Co., Ltd.

Major field:Drug Discovery

Miner field:Cosmetic

Development of dementia preventive/therapeutic agents utilizing HGF inducer derived from natural products

Overview

HGF (hepatocyte growth factor) is an endogenous protein that acts on tissue regeneration and repair, and is effective in the prevention and treatment of various neurodegenerative diseases including dementia. It is known that HGF inducer that increases the production of HGF exists not only in the body but also in foods and natural products.
We have developed a plant extract consisting of 12 kinds of herbs and discovered that it has strong HGF-inducing activity. We are aiming to clarify the HGF inducer and other bioactive substance-inducing factors in this extract and develop it as a
preventive/therapeutic agent for dementia.

Product / Service / PR

    For the purpose of preventing dementia and improving symptoms, we have developed and put on the market a plant extract consisting of 12 kinds of edible herbal extracts based on Kampo prescription.
Address: 1-7-20, Nishitenma, Kita-ku, Osaka 530-0047, Japan  (Contact Person Hideo Oshiro)
TEL: +81-6-6362-1506 FAX: +81-6-6362-1505
Web site: https://www.ioms.co.jp E-mail: oshiro@ioms.co.jp

INTERNATIONAL COOPERATION FOR MEDICAL INNOVATION CO.,LTD

Major field:Drug Discovery

Japan Blood Products Organization

Major field:Drug Discovery

R&D of blood plasma derivares